261 related articles for article (PubMed ID: 31769218)
1. Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma.
Chen Z; Li M; Ma K; Shang G; Liang J; Yin J; Luo J; Zhan C; Shi Y; Wang Q
Cancer Med; 2020 Jan; 9(2):517-529. PubMed ID: 31769218
[TBL] [Abstract][Full Text] [Related]
2. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database.
Wang Y; Liu J; Huang C; Zeng Y; Liu Y; Du J
BMC Cancer; 2021 Feb; 21(1):148. PubMed ID: 33568091
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment strategies for resectable locally advanced primary mucinous adenocarcinoma of the lung.
Gu Y; Zhu H; Deng J; Zhang J; Chen T; Lai S
Cancer Med; 2023 Apr; 12(8):9303-9312. PubMed ID: 36789657
[TBL] [Abstract][Full Text] [Related]
5. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma.
Tang H; Qiao C; Wang Y; Bai C
Can Respir J; 2022; 2022():3676547. PubMed ID: 36091329
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
8. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
Wu C; Rao X; Lin W
Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
10. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L
Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812
[TBL] [Abstract][Full Text] [Related]
11. Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma.
Yan Q; Zheng WJ; Chen QL; Wang BQ; Luo HY; Xue J; Wang XW
Medicine (Baltimore); 2019 Oct; 98(40):e17332. PubMed ID: 31577727
[TBL] [Abstract][Full Text] [Related]
12. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma.
Xu Z; Chen C
Biomed Res Int; 2021; 2021():6663990. PubMed ID: 34036102
[TBL] [Abstract][Full Text] [Related]
13. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database.
Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J
Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223
[TBL] [Abstract][Full Text] [Related]
14. Incidence and survival trends for appendiceal mucinous adenocarcinoma: an analysis of 3237 patients in the Surveillance, Epidemiology, and End Results database.
Yan Q; Zheng W; Luo H; Wang B; Zhang X; Wang X
Future Oncol; 2019 Dec; 15(34):3945-3961. PubMed ID: 31746646
[No Abstract] [Full Text] [Related]
15. A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients.
Sun F; Ma K; Yang X; Li M; Shi Y; Zhan C; Jiang W; Wang Q
Int J Surg; 2017 Jun; 42():11-16. PubMed ID: 28428062
[TBL] [Abstract][Full Text] [Related]
16. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
17. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
Wang J; He L; Tang Y; Li D; Yang Y; Zeng Z
Aging (Albany NY); 2020 Nov; 12(22):23200-23216. PubMed ID: 33221751
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
[No Abstract] [Full Text] [Related]
20. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]